scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1010592564 |
P356 | DOI | 10.1023/A:1022130130855 |
P698 | PubMed publication ID | 9793108 |
P2093 | author name string | Levine J | |
Allingham B | |||
Citrome L | |||
P433 | issue | 4 | |
P921 | main subject | mental health | Q317309 |
P304 | page(s) | 283-300 | |
P577 | publication date | 1998-01-01 | |
P1433 | published in | Psychiatric Quarterly | Q7256226 |
P1476 | title | Utilization of valproate: extent of inpatient use in the New York State Office of Mental Health. | |
P478 | volume | 69 |
Q39994890 | "Stat" medication administration predicts hospital discharge |
Q61886048 | A History of the Pharmacological Treatment of Bipolar Disorder |
Q37356492 | Adjunctive lithium and anticonvulsants for the treatment of schizophrenia: what is the evidence? |
Q35053309 | Antiepileptic drugs in schizophrenia: a review |
Q41472952 | BALANCE: a large simple trial of maintenance treatment for bipolar disorder. |
Q44247120 | Can we conduct some large simple trials in bipolar disorder? |
Q45087215 | Extended-release divalproex sodium for mood stabilization |
Q36302850 | Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia |
Q34616063 | Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial |
Q28205016 | NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development |
Q59222726 | Off-Label Prescribing of Antiepileptic Drugs in Pharmacoresistant Epilepsy: A Cross-Sectional Drug Utilization Study of Tertiary Care Centers in Italy |
Q34098311 | Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. |
Q26772965 | Significant Effect of Valproate Augmentation Therapy in Patients With Schizophrenia: A Meta-analysis Study |
Q37813190 | Switching from brand-name to generic psychotropic medications: a literature review. |
Q73628831 | Valproate treatment and the risk of hyperandrogenism and polycystic ovaries |
Search more.